Company Overview and News

Western Forest Products Inc. Announces Board of Director Changes

2018-04-11 globenewswire
VANCOUVER, British Columbia, April 11, 2018 (GLOBE NEWSWIRE) -- Western Forest Products Inc. (TSX:WEF) (“Western” or the “Company”) announced today that Mr. Barrie Shineton will not be standing for re-election as a director at Western’s Annual and Special Meeting on May 3, 2018, and that Ms. Suzanne Blanchet has been proposed as a nominee for election to the Company’s Board of Directors (the “Board”).

Western Forest Products Inc. Announces Release Date of First Quarter 2018 Results and Conference Call Details

2018-03-29 globenewswire
VANCOUVER, British Columbia, March 29, 2018 (GLOBE NEWSWIRE) -- Western Forest Products Inc. (TSX:WEF) (“Western” or the “Company”) first quarter 2018 financial and operating results will be released on Wednesday, May 2, 2018.

Western Forest Products Inc. 2017 Q4 - Results - Earnings Call Slides

2018-02-20 seekingalpha
The following slide deck was published by Western Forest Products Inc. in conjunction with their 2017 Q4 earnings call.

U.S. demand for Canadian softwood lumber expected to remain high

Softwood lumber duties aren't dampening the spirits of Canadian lumber producers as strong demand from rising U.S. housing starts and tight supply are expected to keep prices high throughout 2018.

UPDATE 3-Canada criticizes U.S. softwood lumber duties, vows to resist

2018-01-03 reuters
WINNIPEG, Manitoba (Reuters) - The Canadian government on Wednesday criticized the United States for a decision to impose duties on certain softwood lumber exports and underlined its determination to fight the move.

Today’s Free Reports, West Fraser Timber, Canfor, Western Forest Products, and Interfor

2017-12-12 accesswire
LONDON, UK / ACCESSWIRE / December 12, 2017 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Forest Products industry: West Fraser Timber, Canfor, Western Forest Products, and Interfor. Access our complimentary up-to-the-minute research reports by becoming an online member now:

UPDATE 2-U.S. finds Canada lumber harms U.S. producers, duties to remain

2017-12-07 reuters
WASHINGTON (Reuters) - The U.S. International Trade Commission said on Thursday it made a final finding that exports of softwood lumber from Canada injure U.S. producers, virtually ensuring that hefty duties on imports of the building material will remain in place for five years.

Gender balance shifting in B.C. forestry as more women enter industry

The gender balance has recently started to tip in British Columbia's forestry industry as more women occupy leadership positions and complete post-secondary studies in one of the province's key sectors.

BRIEF-Western Forest Products announces closure of Englewood Train

2017-11-07 reuters
* Western Forest Products Inc - ‍as a result of closure of train, 34 positions will be eliminated​ Source text for Eikon: Further company coverage:

Western Forest Products Announces Closure of Englewood Train

2017-11-07 marketwired
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 7, 2017) - Western Forest Products Inc. (TSX:WEF) ("Western" or the "Company") today announced the closure of its Englewood logging train. This announcement is consistent with the Company's ongoing efforts to reduce costs and strengthen its competitiveness. Logs will be transported by truck at a lower cost to create efficiencies in the transportation of logs to its mills from northern Vancouver Island forestry operations.

Western Announces Third Quarter 2017 Results

2017-11-03 marketwired
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 2, 2017) - Western Forest Products Inc. (TSX:WEF) ("Western" or the "Company") reported adjusted EBITDA of $32.6 million in the third quarter of 2017, compared to adjusted EBITDA of $35.7 million in the third quarter of 2016, and $47.1 million reported in the second quarter of 2017. Hot, dry weather lowered log harvest and reduced Western's third quarter log and lumber sales volumes.

Western Forest Products Inc. Confirms Record Date of Fourth Quarter 2017 Dividend

2017-11-03 marketwired
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 2, 2017) - Western Forest Products Inc. (TSX:WEF) ("Western" or the "Company") is pleased to confirm that a quarterly dividend of $0.02 per share will be paid with respect to the Company's fourth fiscal quarter of 2017 to shareholders of record as at the close of business on Friday, December 1, 2017 and will be distributed on or about Friday, December 15, 2017.

Canadian Basic Materials Stocks under Review, West Fraser Timber, Canfor, Western Forest Products, and Interfor

2017-10-17 accesswire
LONDON, UK / ACCESSWIRE / October 17, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select stocks with the Forest Products industry and that trades on the Toronto Exchanges. This Morning, our team has regrouped these stocks for study: West Fraser Timber, Canfor, Western Forest Products, and Interfor.

Western Forest Products Inc. Announces Release Date of Third Quarter 2017 Results and Conference Call Details

2017-10-02 marketwired
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 2, 2017) - Western Forest Products Inc. (TSX:WEF) ("Western" or the "Company") third quarter 2017 financial and operating results will be released on Thursday, November 2, 2017.

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...